Garry E Menzel Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Garry E Menzel.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Garry E Menzel. Garry E Menzel is an COO & Executive VP, Finance in Regulus Therapeutics Inc. ($RGLS) and a Director in Stoke Therapeutics, Inc. ($STOK) and a Director in Black Diamond Therapeutics, Inc. ($BDTX) and a President & CEO in TCR2 THERAPEUTICS INC. ($TCRR) and a President and CEO in TCR2 THERAPEUTICS INC. ($TCRR).

Address: C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT, SUITE 210 SAN DIEGO 92121 CA

Companies in which Garry E Menzel is an Insider

Black Diamond Therapeutics, Inc.

Trading Symbol: BDTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Garry E Menzel: Director
Holdings: 51,825 shares
Latest Transaction: Jun 22 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Regulus Therapeutics Inc.

Trading Symbol: RGLS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Garry E Menzel: COO & Executive VP, Finance
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 13 2012
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Stoke Therapeutics, Inc.

Trading Symbol: STOK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Garry E Menzel: Director
Holdings: 0 shares
Latest Transaction: Jan 27 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

TCR2 THERAPEUTICS INC.

Trading Symbol: TCRR
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Garry E Menzel: President and CEO, President & CEO
Holdings: 3,399 shares
Latest Transaction: Mar 08 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Garry E Menzel

Sentiment: All, BDTX, RGLS, STOK, TCRR

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 22 2021BDTXBlack Diamond Ther ...Menzel Garry EDirectorOption ExerciseA12.5515,000188,25015,000
Apr 23 2021BDTXBlack Diamond Ther ...Menzel Garry EDirectorOption ExerciseA24.3314,921363,02814,921
Apr 23 2021BDTXBlack Diamond Ther ...Menzel Garry EDirectorOption ExerciseA24.3314,921363,02814,921
Mar 08 2021TCRRTCR2 THERAPEUTICS ...Menzel Garry EPresident and CEOGrantA16.1268611,0614,0853.4 K to 4.1 K (+20.18 %)
Mar 08 2021TCRRTCR2 THERAPEUTICS ...Menzel Garry EPresident and CEOGrantA10.101,13211,4313,3992.3 K to 3.4 K (+49.93 %)
Jan 27 2021STOKStoke Therapeutics ...Menzel Garry EDirectorOption ExerciseA28.5729,555844,38629,555
Dec 11 2020TCRRTCR2 THERAPEUTICS ...Menzel Garry EPresident and CEOOption ExerciseA31.38245,0007,688,100245,000

View all Garry E Menzel insider transactions.